1CNC Stock Chart & Stats
€55.96
€0.24(0.43%)
At close: 4:00 PM EDT
€55.96
€0.24(0.43%)
Day’s Range― - ―
52-Week Range€19.00 - €88.00
Previous CloseN/A
Volume0.00
Average Volume (3M)87.00
Market Cap
€27.78B
Enterprise Value€48.14K
Total Cash (Recent Filing)€27.06B
Total Debt (Recent Filing)€16.11B
Price to Earnings (P/E)―
Beta0.19
Next Earnings
Oct 27, 2026EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.40
Shares Outstanding493,797,000
10 Day Avg. Volume127
30 Day Avg. Volume87
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.01
Price to Sales (P/S)0.10
P/FCF Ratio4.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€62.27Price Target Upside11.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)3.08
Revenue Forecast (FY)€167.82B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationCentene’s trailing‑twelve‑month operating and free cash flow strength provides durable financial flexibility to fund operations, invest in cost and technology initiatives, and service debt even while GAAP earnings are pressured. Strong cash conversion supports sustained balance‑sheet repair and strategic investments over the next 2–6 months.
Improving Leverage And Active Debt ManagementManagement has materially reduced leverage and repurchased higher‑cost debt while announcing targeted redemptions, improving credit metrics and interest expense profile. Lower leverage increases resilience to enrollment volatility and gives capacity to fund Medicaid pass‑throughs, investments, or further deleveraging over the medium term.
Margin Recovery And Upgraded GuidanceCentene’s upward guidance and measurable HBR improvement reflect sustainable segment margin recoveries (Marketplace, PDP, Medicaid rate tailwinds) and SG&A discipline. If maintained, these structural margin improvements should drive restored profitability and stronger cash generation into 2027, underpinning a multi‑quarter operational turnaround.
Bears Say
Recent Profitability DeteriorationCentene’s recent swing to operating and net losses erodes shareholder returns and raises execution risk despite cash strength. Persistent negative earnings could limit strategic optionality (buybacks/dividends), pressure ROE, and necessitate sustained cost or rate improvements to convert cash flow into consistent GAAP profitability over the coming quarters.
Medicaid Membership AttritionA shrinking Medicaid member base reduces premium scale and dilutes fixed cost absorption, directly pressuring revenue and HBR dynamics in a core business. Sustained attrition can lengthen the margin‑restoration timeline, complicate state contracting economics, and increase sensitivity to rate actions and eligibility verification over the next several quarters.
Nonrecurring Gains And Regulatory/program RiskMaterial Q2 upside included one‑time reconciliation benefits that are unlikely to recur, making the headline improvement partly transient. Coupled with OB3, STARS, and eligibility verification uncertainty, reliance on prior‑period settlements leaves margin recovery vulnerable to regulatory shifts and enrollment/acuity swings in the medium term.
Centene News
1CNC FAQ
What was Centene’s price range in the past 12 months?
Centene lowest stock price was €19.00 and its highest was €88.00 in the past 12 months.
What is Centene’s market cap?
Centene’s market cap is €27.78B.
When is Centene’s upcoming earnings report date?
Centene’s upcoming earnings report date is Oct 27, 2026 which is in 90 days.
How were Centene’s earnings last quarter?
Centene released its earnings results on Jul 28, 2026. The company reported €2.203 earnings per share for the quarter, beating the consensus estimate of €0.952 by €1.251.
Is Centene overvalued?
According to Wall Street analysts Centene’s price is currently Undervalued.
Does Centene pay dividends?
Centene does not currently pay dividends.
What is Centene’s EPS estimate?
Centene’s EPS estimate is 0.08.
How many shares outstanding does Centene have?
Centene has 493,797,000 shares outstanding.
What happened to Centene’s price movement after its last earnings report?
Centene reported an EPS of €2.203 in its last earnings report, beating expectations of €0.952. Following the earnings report the stock price went down -3.753%.
Which hedge fund is a major shareholder of Centene?
Currently, no hedge funds are holding shares in IT:1CNC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Centene Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€62.27 (11.27% Upside)
€62.27 (11.27% Upside)
Blogger Sentiment
Bullish
IT:1CNC Sentiment 75%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $5.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
136.95%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.74%
Trailing 12-Months
Company Description
Centene
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
1CNC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid financial momentum and tangible operational progress: a Q2 EPS beat, raised full-year EPS guidance, margin improvements in Marketplace and PDP, better-than-expected state rate development for Medicaid, strong cash flow and balance-sheet improvements, and measurable cost-management wins (including AI-enabled initiatives). However, the company faces meaningful near-term headwinds: membership attrition (especially in Medicaid expansion), acuity shifts that could pressure medical cost ratios, regulatory/program uncertainty (OB3, STARS, eligibility verification), and a portion of Q2 upside tied to nonrecurring prior-period settlements. On balance, the positive guidance revisions, margin recoveries in key segments, cash and debt improvement, and demonstrated operating discipline outweigh the near-term risks flagged by management.View all IT:1CNC earnings summaries1CNC Revenue Breakdown
88.08% Premium
1.55% Service
10.37% Premium tax
1CNC Stock 12 Month Forecast
Average Price Target
€62.27
▲(11.27% Upside)